Low Serum Lysophospholipids Predict Increased In‐Hospital Mortality in Patients With Acute Heart Failure

20260 citationsJournal Articlegold Open Access

Authors

Iva Klobučar · Sisters of Charity Hospital

Gudrun Pregartner · Medical University of Graz

Gerald N. Rechberger · University of Graz

Thomas O. Eichmann · Medical University of Graz

Ines Potočnjak · Catholic University of Croatia

Matias Trbušić · University of Zagreb

Hansjörg Habisch

Abstract

Low serum levels of lysophosphatidylethanolamine 20:4, lysophosphatidylcholine 20:4, lysophosphatidylcholine 14:0, and lysophosphatidylethanolamine 18:1 were independently associated with in-hospital mortality in acute heart failure. These findings suggest that specific lysophospholipids may serve as novel prognostic biomarkers, warranting validation in larger studies to confirm their clinical applicability.

Topics & Keywords

Metabolomics and Mass Spectrometry Studies Sepsis Diagnosis and Treatment Heart Failure Treatment and Management

UN Sustainable Development Goals

Reduced inequalities

Publication Details

Published in: Journal of the American Heart Association

Volume 15, Issue 2, pp. e043828-e043828

DOI: 10.1161/jaha.125.043828

Field-Weighted Citation Impact: 0.00